Sign in
Not yet taking people in United StatesPhase 1

Nanopulse Laser Therapy

Key facts

Who runs it
The University of Texas Medical Branch, Galveston
Where
Galveston, United StatesSee the site
Trial code
Status
Not yet recruiting
Phase
Phase 1
People taking part
30 people, planned
Starts
1 Dec 2026
Expected to end
May 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Nano-Pulsed Laser Therapy (NPLT)
Record updated
6 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adults aged 18 years or older at the time of enrollment
  • Confirmed diagnosis of moderate to severe TBI (clinical assessment and radiographic evidence)
  • Admission to the neurosurgical or neurocritical care service with anticipated need for intracranial monitoring (e.g., microdialysis, ICP probe)
  • Able to initiate treatment within 48 hours of admission
  • Informed consent obtained from patient or legally authorized representative

Who cannot take part

  • Known allergy or hypersensitivity to adhesives or device components
  • Patients younger than 18 years of age
  • Known or suspected pregnancy (verified via urine pregnancy test for females of childbearing age)
  • Incarcerated individuals or prisoners
  • Patients with pre-existing implanted cranial devices (e.g., deep brain stimulators) that may interfere with NPLT
  • Patients with severe scalp injury or open wounds at intended treatment site

Where in United States

  • University of Texas Medical BranchGalveston, United StatesContact: Patrick Karas, MDNot yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).

The 2 groups in the trial

  • Nano-Pulsed Laser Therapy (NPLT)Treatment being tested

    Participants receive NPLT administered transcranially.

  • Standard of Care with Sham NPLTNo study treatment, for comparison

    Participants receive standard care with sham NPLT (laser delivery obstructed but device setup identical).

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Biomarker Responsiveness of Nanopulse Laser Therapy in Treatment of Traumatic Brain Injury
Record updated
6 November 2026